Episode 17 - Long COVID Clinical Trials with Dr. Michael Peluso
Failed to add items
Add to basket failed.
Add to wishlist failed.
Remove from wishlist failed.
Adding to library failed
Follow podcast failed
Unfollow podcast failed
Episode 17 - Long COVID Clinical Trials with Dr. Michael Peluso
-
Narrated by:
-
By:
Summary
In this episode of the Long COVID Clinical Podcast, hosted by Drs. Anita Chopra, Tiffany Walker, Andrew Schamess, and Aaron Friedberg, Dr. Michael Peluso shares groundbreaking insights into long COVID research. Dr. Peluso is an infectious disease physician and leader of the Long-term Impact of Infection with Novel Coronavirus (LIINC) study at UCSF. The discussion highlights the persistent presence of SARS-CoV-2 in the gut and immune system, revealing elevated immune activation in post-COVID patients and unexpected virus fragment locations. Dr. Peluso explores pivotal clinical trials with antivirals and monoclonal antibodies, emphasizing the need for better biomarkers and collaborative research efforts to accelerate diagnostics and therapies. His work aims to transform long COVID from a mysterious condition into a manageable illness, offering hope for millions affected.
Edited and Produced by Christopher Chiu and Carissa Lee